Canan G. Nebigil
Laboratory of Cardio-oncology and Medicinal Chemistry, CNRS, University of Strasbourg, FranceLaboratory of Cardio-oncology and Medicinal Chemistry, CNRS, University of Strasbourg, France
University of Strasbourg
France
Biography
Canan Nebigil is a Director of Research at CNRS. After her Pharm.D degree, she obtained her PhD at the University of Tennessee, USA and postdoctoral trainings, including at Duke University, NIH, Bethesda, and IGBMC, Strasbourg. Her team has been created with ATIP/Avenir CNRS, a young investigator award in Strasbourg. Her team has identified several fundamental mechanisms by which prokineticin signaling is involved in heart development and diseases associated with drug discovery. She obtained several scintific awards including, FRM, ESC, and CNRS. She is a coordinator of a EU project. She has 56 publications (H:28) and is editor of several journals. Her team was the first to explore the role of a new hormone, prokineticin, on cardiac physiopathology and metabolic disorders.
Research Interest
Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of Prokineticin Receptor-1 (PKR1)